CHIP (Clonal Hematopoiesis of Indeterminate Potential): Potent and Newly Recognized Contributor to Cardiovascular Risk

被引：66
|
作者：
Libby, Peter [1 ]
Ebert, Benjamin L. [2 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
来源：
CIRCULATION | 2018年 / 138卷 / 07期
关键词：
atherosclerosis; cardiovascular diseases; hematologic neoplasms; inflammation; prevention and control; risk factors; ATHEROSCLEROSIS;
D O I：
10.1161/CIRCULATIONAHA.118.034392
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：666 / 668
页数：3
相关论文
共 50 条
  • [1] The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor
    Sidlow, Robert
    Lin, Amy E.
    Gupta, Dipti
    Bolton, Kelly L.
    Steensma, David P.
    Levine, Ross L.
    Ebert, Benjamin L.
    Libby, Peter
    JAMA CARDIOLOGY, 2020, 5 (08) : 958 - 961
  • [2] Clonal hematopoiesis of indeterminate potential (CHIP): A potential contributor to atherlosclerotic cardio/cerebro-vascular diseases?
    Li, Fei
    Wu, Xiaojing
    Zhou, Qi
    Zhu, Dennis Weixi
    GENES & DISEASES, 2018, 5 (02) : 75 - 76
  • [3] Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases—an updated systematic review
    Nagendra Boopathy Senguttuvan
    Vinodhini Subramanian
    Vettriselvi Venkatesan
    T. R. Muralidharan
    Kavitha Sankaranarayanan
    Journal of Genetic Engineering and Biotechnology, 19
  • [4] Clonal hematopoiesis of indeterminate potential and cardiovascular disease
    Saadatagah, Seyedmohammad
    Ballantyne, Christie M.
    TRANSLATIONAL RESEARCH, 2023, 255 : 152 - 158
  • [5] Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Disease
    Preetham Kumar
    Stephen L. Kopecky
    Eric H. Yang
    Ohad Oren
    Current Oncology Reports, 2020, 22
  • [6] Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Disease
    Kumar, Preetham
    Kopecky, Stephen L.
    Yang, Eric H.
    Oren, Ohad
    CURRENT ONCOLOGY REPORTS, 2020, 22 (09)
  • [7] Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk
    Tobias, Deirdre K.
    Manning, Alisa K.
    Wessel, Jennifer
    Raghavan, Sridharan
    Westerman, Kenneth E.
    Bick, Alexander G.
    Dicorpo, Daniel
    Whitsel, Eric A.
    Collins, Jason
    Correa, Adolfo
    Cupples, L. Adrienne
    Dupuis, Josee
    Goodarzi, Mark O.
    Guo, Xiuqing
    Howard, Barbara
    Lange, Leslie A.
    Liu, Simin
    Raffield, Laura M.
    Reiner, Alex P.
    Rich, Stephen S.
    Taylor, Kent D.
    Tinker, Lesley
    Wilson, James G.
    Wu, Peitao
    Carson, April P.
    Vasan, Ramachandran S.
    Fornage, Myriam
    Psaty, Bruce M.
    Kooperberg, Charles
    Rotter, Jerome I.
    Meigs, James
    Manson, JoAnn E.
    DIABETES CARE, 2023, 46 (11) : 1978 - 1985
  • [8] Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease
    Marnell, Christopher S.
    Bick, Alexander
    Natarajan, Pradeep
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2021, 161 : 98 - 105
  • [9] Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases-an updated systematic review
    Senguttuvan, Nagendra Boopathy
    Subramanian, Vinodhini
    Venkatesan, Vettriselvi
    Muralidharan, T. R.
    Sankaranarayanan, Kavitha
    JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2021, 19 (01)
  • [10] A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential
    Yu, Xiongkai
    Qian, Ningjing
    Wang, Yaping
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (03) : 2813 - 2822
12345